Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chondroitin 6-sulfate (C6S), also known as chondroitin sulfate C, is a sulfated glycosaminoglycan (GAG) composed of alternating glucuronic acid and N-acetylgalactosamine residues sulfated at the C6 position. It is a major component of the extracellular matrix (ECM) in cartilage, blood vessels, and the central nervous system, where it plays critical roles in maintaining structural integrity, regulating cell signaling, and modulating cell adhesion and migration. In pathological states, such as Mucopolysaccharidosis IVA (Morquio A syndrome), a deficiency in the lysosomal enzyme N-acetylgalactosamine-6-sulfatase (GALNS) leads to the toxic accumulation of C6S and keratan sulfate, which is treated with the enzyme replacement therapy elosulfase alfa. Additionally, altered sulfation patterns of chondroitin sulfate, including oncofetal chondroitin sulfate (ofCS) which is highly enriched in C6S motifs, are aberrantly expressed in solid tumors and the tumor microenvironment, making them attractive targets for novel cancer therapies like Vartumab. In central nervous system injuries, C6S is upregulated in the glial scar and acts as a barrier to axonal regeneration, which researchers are targeting using C6S-binding peptides and chondroitinase enzymes to promote functional recovery.
Enzymatic degradation of accumulated glycosaminoglycans to restore tissue homeostasis; competitive binding to block inhibitory or pro-tumorigenic interactions; targeting of oncofetal chondroitin sulfate to deliver cytotoxic payloads (ADCs) or recruit T-cells.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chondroitin 6-sulfate (C6S).